1+ day, 7+ hour ago   (704+ words) Cardiovascular medicine is quietly undergoing a structural rethink, and the change begins with the order of operations....

1+ day, 7+ hour ago   (90+ words) Artificial intelligence has become an increasingly powerful tool in the search for new medicines, but a persistent problem has haunted the field: neural networks that invent molecules are remarkably creative yet notoriously unreliable. They can propose chemical structures that look…...

1+ day, 8+ hour ago   (721+ words) A new qualitative study from China offers one of the most detailed maps to date of what patients with cardiovascular-kidney-metabolic syndrome actually value about their health, and the picture that emerges is strikingly broader than the clinical targets that dominate…...

1+ day, 14+ hour ago   (55+ words) Metastatic triple-negative breast cancer remains one of the most formidable challenges in oncology. Lacking the estrogen receptor, progesterone receptor, and HER2 that anchor targeted therapies in other breast cancer subtypes, this aggressive disease leaves patients with few options once first-line treatment…...

1+ day, 19+ hour ago   (832+ words) An investigational antibody-drug conjugate that simultaneously targets two of the most important growth-driving proteins in lung cancer has delivered encouraging clinical results in patients whose tumors had already resisted modern targeted therapy, according to data presented at the International Association…...

2+ day, 7+ hour ago   (804+ words) The Journal of Pharmaceutical Investigation, a peer-reviewed publication covering pharmaceutical sciences and drug delivery research, has reached a new milestone in its editorial visibility, with abstracting and indexing records confirming its inclusion in Science Citation Index Expanded, widely known as…...

2+ day, 7+ hour ago   (1349+ words) {“title”:”AI-Enabled Clinical Trials Are Poised to Transform How New Medicines Are Tested”,”html”:”Clinical trials have long been the slowest, most expensive and most unpredictable stage of medical research. A promising molecule identified in the laboratory can take a…...

3+ day, 8+ hour ago   (64+ words) ETHRWorld.com As per EY’s 2026 report on ‘Pharma’s new architecture,’ over 80 per cent of pharma companies reported shortages in specialised areas such as clinical research, AI-driven drug discovery, regulatory sciences, gene editing, and computational biology. Get in-depth Industry Insights and…...

4+ day, 16+ hour ago   (191+ words) Nature Genetics (2026) Cite this article In February 2026, the FDA published a draft guidance establishing a plausible mechanism framework for individualized therapies that target rare genetic diseases. The framework is a genuine advance, but its five criteria are not equally tractable,…...

5+ day, 15+ hour ago   (556+ words) The FDA-approved drug it helped developed saw a nearly 80% sequential rise in sales. It also booked $10 million in upfront payments with a business partner. Pioneering gene-editing company CRISPR Therapeutics(NASDAQ: CRSP) was a well-performing biotech stock in August. Its shares…...